Probiotics in inflammatory bowel disease: is it all gut flora modulation?

被引：68

作者：

Ghosh, S ^{[1
]}

van Heel, D ^{[1
]}

Playford, RJ ^{[1
]}

机构：

[1] Hammersmith Hosp, Imperial Coll London, Fac Med, Div Med,Gastroenterol Sect, London W12 0NN, England

来源：

GUT | 2004年 / 53卷 / 05期

关键词：

D O I：

10.1136/gut.2003.034249

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Understanding probiotic action may permit modulation of the immune system, both locally and systemically.

引用

页码：620 / 622

页数：3

共 28 条

[11] Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, JP
Chamaillard, M
Zouali, H
Lesage, S
Cézard, JP
Belaiche, J
Almer, S
Tysk, C
O'Morain, CA
Gassull, M
Binder, V
Finkel, Y
Cortot, A
Modigliani, R
Laurent-Puig, P
Gower-Rousseau, C
Macry, J
Colombel, JF
Sahbatou, M
Thomas, G
[J]. NATURE, 2001, 411 (6837) : 599 - 603
[12] Host recognition of bacterial muramyl dipeptide mediated through NOD2
Inohara, N
Ogura, Y
Fontalba, A
Gutierrez, O
Pons, F
Crespo, J
Fukase, K
Inamura, S
Kusumoto, S
Hashimoto, M
Foster, SJ
Moran, AP
Fernandez-Luna, JL
Nuñez, G
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5509 - 5512
[13] Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp bulgaricus NIAI B6
Kitazawa, H
Watanabe, H
Shimosato, T
Kawai, Y
Itoh, T
Saito, T
[J]. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2003, 85 (1-2) : 11 - 21
[14] Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells
Lammers, KM
Brigidi, P
Vitali, B
Gionchetti, P
Rizzello, F
Caramelli, E
Matteuzzi, D
Campieri, M
[J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 38 (02): : 165 - 172
[15] Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
Madsen, KL
Doyle, JS
Jewell, LD
Tavernini, MM
Fedorak, RN
[J]. GASTROENTEROLOGY, 1999, 116 (05) : 1107 - 1114
[16] Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
McCarthy, J
O'Mahony, L
O'Callaghan, L
Sheil, B
Vaughan, EE
Fitzsimons, N
Fitzgibbon, J
O'Sullivan, GC
Kiely, B
Collins, JK
Shanahan, F
[J]. GUT, 2003, 52 (07) : 975 - 980
[17] Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
Mimura, T
Rizzello, F
Helwig, U
Poggioli, G
Schreiber, S
Talbot, IC
Nicholls, RJ
Gionchetti, P
Campieri, M
Kamm, MA
[J]. GUT, 2004, 53 (01) : 108 - 114
[18] Immune networks in animal models of inflammatory bowel disease
Mizoguchi, A
Mizoguchi, E
Bhan, AK
[J]. INFLAMMATORY BOWEL DISEASES, 2003, 9 (04) : 246 - 259
[19] A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y
Bonen, DK
Inohara, N
Nicolae, DL
Chen, FF
Ramos, R
Britton, H
Moran, T
Karaliuskas, R
Duerr, RH
Achkar, JP
Brant, SR
Bayless, TM
Kirschner, BS
Hanauer, SB
Nuñez, G
Cho, JH
[J]. NATURE, 2001, 411 (6837) : 603 - 606
[20] Interaction of lactic acid bacteria with the gut immune system
Perdigón, G
Galdeano, CM
Valdez, JC
Medici, M
[J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (Suppl 4) : S21 - S26

← 1 2 3 →